Clinical Trials Directory

Trials / Completed

CompletedNCT05824273

The INSPIRE-Lung Study

Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
512 (actual)
Sponsor
Hackensack Meridian Health · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Accepted

Summary

LungTalk and leveraging Facebook-targeted Advertisement (FBTA) addresses the call to develop and test multi-level, cancer communication interventions using innovative methods and designs. The study's long term goal is to increase lung cancer screening uptake among appropriate, high-risk individuals nationwide.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLungTalkLungTalk is a 10-15 minute long computer-tailored health communication and decision-making tool.
BEHAVIORALNon-tailored intervention - Standard of practiceACS Lung Screening Informational Video

Timeline

Start date
2023-08-02
Primary completion
2024-07-30
Completion
2024-07-30
First posted
2023-04-21
Last updated
2025-11-21
Results posted
2025-11-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05824273. Inclusion in this directory is not an endorsement.

The INSPIRE-Lung Study (NCT05824273) · Clinical Trials Directory